These results suggest that fractalkine and CX3CR1 signaling might act as a neuroprotective mechanism through the microglial activity modulation in the early stage of brain injury while this signal seems to disappear when neuronal damage is established [91]. This evidence concerns the gene CX3CR1 and injury.